Heart repair by reprogramming non-myocytes with cardiac transcription factors

Nature

Volumn 485, Issue 7400, 2012, Pages 599-604

  Song, Kunhua ^a   Nam, Young Jae ^a,b   Luo, Xiang ^b   Qi, Xiaoxia ^b   Tan, Wei ^a   Huang, Guo N ^a   Acharya, Asha ^a   Smith, Christopher L ^a   Tallquist, Michelle D ^a   Neilson, Eric G ^c   Hill, Joseph A ^a,b   Bassel Duby, Rhonda ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR HAND2; TRANSCRIPTION FACTOR MEF2C; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; PROTEIN S 100; S100A4 PROTEIN, MOUSE; TCF21 PROTEIN, MOUSE;

GENE EXPRESSION; INJURY; MAMMAL; PATHOLOGY; PHENOTYPE; RODENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HEART SURGERY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; ANIMAL; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CYTOLOGY; GENETICS; HEART; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; REGENERATIVE MEDICINE; TAIL;

MAMMALIA; MUS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; FIBROBLASTS; HEART; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NUCLEAR REPROGRAMMING; PHENOTYPE; REGENERATIVE MEDICINE; S100 PROTEINS; TAIL; TRANSCRIPTION FACTORS;

EID: 84863626782     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11139     Document Type: Article

References (41)

1. Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. & Murray, C. J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1747-1757 (2006).
2. Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080 (2011).
3. Yacoub, M., Suzuki, K. & Rosenthal, N. The future of regenerative therapy in patients with chronic heart failure. Nat. Clin. Pract. Cardiovasc. Med. 3 (Suppl. 1), S133-S135 (2006).
4. Menasche, P. Cell-based therapy for heart disease: a clinically oriented perspective. Mol. Ther. 17, 758-766 (2009).
5. Hoover-Plow, J. & Gong, Y. Challenges for heart disease stem cell therapy. Vasc. Health Risk Manag. 8, 99-113 (2012).
6. Perin, E. C. et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. J. Am. Med. Assoc., (2012).
7. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
8. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
9. Tapscott, S. J. et al. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242, 405-411 (1988).
10. Wang, Z., Wang, D. Z., Pipes, G. C. & Olson, E. N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl Acad. Sci. USA 100, 7129-7134 (2003).
11. Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041 (2010).
12. Caiazzo, M. et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476, 224-227 (2011).
13. Jugdutt, B. I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108, 1395-1403 (2003).
14. Olson, E. N. Gene regulatory networks in the evolution and development of the heart. Science 313, 1922-1927 (2006).
15. Bondue, A. & Blanpain, C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ. Res. 107, 1414-1427 (2010).
16. Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
17. Zang, M. X., Li, Y., Wang, H., Wang, J. B. & Jia, H. T. Cooperative interaction between the basic helix-loop-helix transcription factor dHAND and myocyte enhancer factor 2Cregulatesmyocardial gene expression. J. Biol. Chem. 279, 54258-54263 (2004).
18. Dai, Y. S., Cserjesi, P., Markham, B. E. & Molkentin, J. D. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. J. Biol. Chem. 277, 24390-24398 (2002).
19. Garg, V. et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424, 443-447 (2003).
20. Ghosh, T. K. et al. Physical interaction between TBX5 and MEF2C is required for early heart development. Mol. Cell. Biol. 29, 2205-2218 (2009).
21. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
22. Porter, K. E. & Turner, N. A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123, 255-278 (2009).
23. Byun, J. et al. Myocardial injury-induced fibroblast proliferation facilitates retroviral-mediated gene transfer to the rat heart in vivo. J. Gene Med. 2, 2-10 (2000).
24. Bhowmick, N. A. et al. TGF-b signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851 (2004).
25. Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Med. 13, 952-961 (2007).
26. Schneider, M. et al. S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc. Res. 75, 40-50 (2007).
27. Loffredo, F. S. et al. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8, 389-398 (2011).
28. Beyer, E. C. Gap junctions. Int. Rev. Cytol. 137C, 1-37 (1993).
29. Saffitz, J. E., Green, K. G., Kraft, W. J., Schechtman, K. B. & Yamada, K. A. Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium. Am. J. Physiol. Heart Circ. Physiol. 278, H1662-H1670 (2000).
30. Acharya, A., Baek, S. T., Banfi, S., Eskiocak, B. & Tallquist, M. D. Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis 49, 870-877 (2011).
31. Hsieh, P. C. et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nature Med. 13, 970-974 (2007).
32. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to b-cells. Nature 455, 627-632 (2008).
33. Tandan, S. et al. Physical and functional interaction between calcineurin and the cardiac L-type Ca21 channel. Circ. Res. 105, 51-60 (2009).
34. Laugwitz, K. L. et al. Postnatal isl11 cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653 (2005).
35. Luo, X. et al. Aberrant localization of intracellular organelles, Ca21 signaling, and exocytosis in Mist1 null mice. J. Biol. Chem. 280, 12668-12675 (2005).
36. Grynkiewicz, G., Poenie, M. & Tsien, R. Y. A new generation of Ca21 indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450 (1985).
37. Hardy, M. E. et al. Validation of a voltage-sensitive dye (di-4-ANEPPS)-based method for assessing drug-induced delayed repolarisation in beagle dog left ventricular midmyocardial myocytes. J. Pharmacol. Toxicol. Methods 60, 94-106 (2009).
38. Kitamura, T. et al. Efficient screening of retroviral cDNAexpression libraries. Proc. Natl Acad. Sci. USA 92, 9146-9150 (1995).
39. Subramaniam, A. et al. Tissue-specific regulation of the a-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266, 24613-24620 (1991).
40. Sohal, D. S. et al. Temporally regulated and tissue-specific genemanipulations in the adult andembryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20-25 (2001).
41. Russell, J. L. et al. A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Circ. Res. 108, 51-59 (2011).